~ Institutional investors include affiliates of Off the Chain Capital and Discovery Capital Management ~ ‍ MINNEAPOLIS, July 26, 2024 (GLOBE NEWSWIRE) – OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the

– Cytel’s software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies – ‍MINNEAPOLIS, July 22, 2024 (GLOBE NEWSWIRE) – Further to

– Regains compliance with Nasdaq minimum closing bid price rule – – Secures financing from institutional investor to support aggressive growth plans – ‍ MINNEAPOLIS, June 24, 2024 (GLOBE NEWSWIRE)– OneMedNetCorporation

– Partner’s software products and services are utilized by hundreds of life science organizations, including the top 30 biopharmaceutical companies – ‍ MINNEAPOLIS, June 14, 2024 (GLOBE NEWSWIRE) – OneMedNet Corporation

Secures new life science company customer through this globally recognized and trusted new channel MINNEAPOLIS, June 06, 2024 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the

OneMedNet’s new iRWD™ platform customer impacts more than 150 million patients each year MINNEAPOLIS, May 29, 2024 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), the leading